Microorganism |
MIC50 (μg/ml) |
MIC90 (μg/ml) |
Range (μg/ml) |
Antimicrobial  |
Reference |
Staphylococcus xylosus |
8 |
8 |
? - ? |
Pexiganan  |
14 |
Staphylococcus xylosus |
- |
- |
≤0.125 - ? |
MSI-78 (Peptide)  |
65 |
Staphylococcus xylosus |
- |
- |
14 - ? |
Recombinant lysostaphin  |
1526 |
Staphylococcus xylosus (ATCC 29971) |
- |
- |
6400 - ? |
Catechin  |
1212 |
Staphylococcus xylosus (LQC 5156) |
- |
- |
2 - ? |
Ampicillin (Omnipen)  |
836 |
Staphylococcus xylosus (LQC 5156) |
- |
- |
2 - ? |
Erythromycin (E-mycin, Ery-tab, Benzamycin)  |
836 |
Staphylococcus xylosus (LQC 5156) |
- |
- |
2 - ? |
Tetracycline (Sumycin, Achromycin V, Steclin)  |
836 |
Staphylococcus xylosus (LQC 5156) |
- |
- |
8 - ? |
Chloramphenicol (Chloromycetin)  |
836 |
Staphylococcus xylosus (LQC 5156) |
- |
- |
8 - ? |
Streptomycin  |
836 |
Staphylococcus xylosus (LQC 5156) |
- |
- |
>128 - ? |
Bacitracin (Baci-IM)  |
836 |
Staphylococcus xylosus (LQC 5156) |
- |
- |
>128 - ? |
Novobiocin (Albamycin)  |
836 |
Staphylococcus xylosus |
>0.12 |
>8 |
≤0.06 - >8 |
Clindamycin (Cleocin)  |
472 |
Staphylococcus xylosus |
0.25 |
0.5 |
0.03 - 1 |
Tigecycline (GAR-936, Tigacyl)  |
472 |
Staphylococcus xylosus |
0.25 |
0.5 |
0.06 - 2 |
Daptomycin (Cubicin)  |
472 |
Staphylococcus xylosus |
0.25 |
0.5 |
≤0.25 - >8 |
Quinupristin/Dalfopristin (Synercid)  |
472 |
Staphylococcus xylosus |
1 |
1 |
0.12 - 2 |
Linezolid (PNU-100766, U-100766, Zyvox)  |
472 |
Staphylococcus xylosus |
1 |
2 |
0.25 - 4 |
Vancomycin (Vancocyn, Lyphocin)  |
472 |
Staphylococcus xylosus |
>1 |
>2 |
≤0.5 - >2 |
Co-trimoxazole (Trimethoprim-sulfamethoxazole, TMP-SMX)  |
472 |
Staphylococcus xylosus |
>2 |
>2 |
≤0.06 - >2 |
Oxacillin (Prostaphilin, Bactocil, Prostaphlin)  |
472 |
Staphylococcus xylosus |
>2 |
>4 |
≤0.03 - >4 |
Levofloxacin (Levaquin, Quixin)  |
472 |
Staphylococcus xylosus |
>2 |
>8 |
≤2 - >8 |
Tetracycline (Sumycin, Achromycin V, Steclin)  |
472 |
Staphylococcus xylosus |
2 |
8 |
≤2 - >16 |
Teicoplanin (Targocid)  |
472 |